Oligomers count

attyloid’s sFIDA platform technology offers a cutting-edge approach for the quantitative detection of single oligomers and aggregates, which serve as biomarkers of CNS disorders such as Alzheimer’s Disease and Parkinson’s Disease.

sFIDA technology

aggregates under the spotlight

The sFIDA platform integrates the precision of a selective immunoassay with the superior sensitivity of fluorescence microscopy to count single oligomers, aggregates, and particles. As a result, sFIDA can detect these biomarkers at unprecedented levels of sensitivity and specificity.

applications

CNS
biomarkers

  • MoA validation

  • Patient selection and stratification

  • Target engagement assaying

  • Drug efficacy testing

subvisible particle analysis

  • R&D of biologicals

  • Cell culture screening

  • Formulation development

  • QC in bioproduction

viral particle
analysis

  • Vaccine production

  • Protein expression

  • Viral therapeutics

  • Antiviral development

we are

attyloid is an academicy spin-off dedicated to the scientific rigor that the complex fields of protein misfolding and Central Nervous System (CNS) diseases demand. Our research plays a critical role in diagnosing and understanding these diseases and paving the way for innovative therapeutics.

interested in our

cutting-edge technology?

sFIDA’s efficiency in numbers

oligomer sizes

1.000 nm

sample volume

1.000 µl

detection limit

1.000 fM

dynamic range orders of magnitude

1

latest news

  • Meet us at the Düsseldorf-Jülich Symposium 2023

    December 4, 2023

    Oliver Bannach, CEO of attyloid, will present at the 5th Düsseldorf-Jülich Symposium on Neurodegenerative ...

  • sFIDA Technology Reveals New Insights into Protein Aggregation in Psychotic Disorders

    September 5, 2023

    In a pioneering study that could have wide-reaching implications for psychiatric research, scientists have ...

  • attyloid’s sFIDA Technology Key in Revealing COVID-19’s Potential Neurodegenerative Impact

    August 21, 2023

    A new study has utilized attyloid's cutting-edge Single Molecule Fluorescence Intensity Distribution Analysis (sFIDA) ...